Live Breaking News & Updates on Tom Heineman

Stay updated with breaking news from Tom heineman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United States , Matthew Coffey , Jim Allison , Thomas Heineman , Tom Heineman , Raymond James , Matt Coffey , Jon Patton , John Newman , Rahul Sarugaser , Pancreatic Cancer Action Network , American Society For Clinical Oncology , Oncolytics Biotech Inc , Oncolytics Biotech , Call Transcript May , First Quarter , Investor Relations , Chief Executive Officer , Chief Financial Officer , Kirk Look , Chief Medical Officer , American Society , Clinical Oncology , Paying Countries , Marine Biologists , Highest Credit Card Debt ,

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to Oncolytics Biotech s Fourth Quarter and Full Year 2023 Conference Call. All participants are now in a listen-only mode. ....

San Diego , United States , Louise Chen , John Newman , Matt Coffey , Patrick Trucchio , Soumit Roy , Jon Patton , Allison Hagerman , Carvey Leung , Pat Andrews , Luis Santos , Tom Heineman , Manufacturing Organization , Contract Development , Product Development , American Cancer Society , Pancreatic Cancer Action Network , Jones Research , Oncolytics Biotech , Global Coalition For Adaptive Research , Oncolytics Biotech Inc , Call Transcript March , Fourth Quarter , Full Year , Investor Relations ,

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript March 9, 2024 Oncolytics Biotech Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to Oncolytics Biotech’s Fourth Quarter and Full Year 2023 Conference Call. All participants […] ....

United States , San Diego , Allison Hagerman , Pat Andrews , Matt Coffey , Tom Heineman , Product Development , Pancreatic Cancer Action Network , American Cancer Society , Oncolytics Biotech , Global Coalition For Adaptive Research , Manufacturing Organization , Contract Development , Chief Executive Officer , Chief Financial Officer , Kirk Look , Chief Medical Officer , Vice President , Pancreatic Ductal Adenocarcinoma , Global Coalition , Adaptive Research , Investor Relations , New Year , Wall Street Picked These , Pancreatic Cancer , Oncolytics Biotech Inc ,

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript November 3, 2023 Oncolytics Biotech Inc. misses on earnings expectations. Reported EPS is $-0.1 EPS, expectations were $-0.07. Operator: Good morning, and welcome to Oncolytics Biotech’s Third Quarter 2023 Conference Call. All participants are now in listen-only mode. There will be a question-and-answer session at the […] ....

Thomas Heineman , Matt Coffey , Roche Incyte , Tom Heineman , European Society For Medical Oncology , Oil Refinery Stocks To , Global Head Of Business Development , Chief Medical Officer , Global Head , Business Development , Andrew De Guttadauro , Chief Financial Officer , Kirk Look , European Society , Medical Oncology , Registrational Trials , Precision Promise Phase , Chief Medical , Precision Promise , Registrational Studies , Oil Refinery Stocks To Buy , Small Cap Biotech Stocks , Massive Potential According , Pancreatic Cancer , Pancreatic Cancer , Breast Cancer ,

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript

Operator: Good morning, and welcome to Oncolytics Biotech s Third Quarter 2023 Conference Call. All participants are now in listen-only mode. ....

Roche Incyte , Jon Patton , Thomas Heineman , Matt Coffey , Louise Chen , Tom Heineman , John Newman , Global Head Of Business Development , Oncolytics Biotech Inc , Oil Refinery Stocks To , European Society For Medical Oncology , Oncolytics Biotech , Call Transcript November , Third Quarter , Investor Relations , Chief Medical Officer , Global Head , Business Development , Andrew De Guttadauro , Chief Financial Officer , Kirk Look , European Society , Medical Oncology , Registrational Trials , Precision Promise Phase , Chief Medical ,